ArticleCancer science2025

Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.

Akihiro Nishiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.